Curative Biotechnology

(OTC) CUBT

Current Price$0.90

Market Cap$8.18M

Since IPO (2008)-100%

5 Year-91%

1 Year-18%

1 Month-25%

Curative Biotechnology Financials at a Glance

Market Cap

$8.18M

Revenue (TTM)

$0.00

Net Income (TTM)

-$2.13M

EPS (TTM)

-$0.35

P/E Ratio

-3.45

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.90

Volume

4,407

Open

$0.82

Price

$0.90

Volume

4,407

Open

$0.82

Previous Close

$0.90

Daily Range

$0.65 - $1.05

52-Week Range

$0.03 - $1.99

Estimated Earnings Date

May 15, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.90

Volume

4,407

Open

$0.82

Previous Close

$0.90

Daily Range

$0.65 - $1.05

52-Week Range

$0.03 - $1.99

Estimated Earnings Date

May 15, 2026

CUBT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Curative Biotechnology

Industry

Biotechnology

Sector

Health Care

Employees

CEO

I. Richard Garr

Website

www.curativebiotech.com

Headquarters

Palm Beach Gardens, FL 33410, US

CUBT Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

36.18%

Return on Capital

N/A

Return on Assets

-103.16%

Earnings Yield

-28.99%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.18M

Shares Outstanding

6.82M

Volume

4.41K

Avg. Volume

1.81K

Financials (TTM)

Gross Profit

-$87.69K

Operating Income

-$1.53M

EBITDA

-$1.44M

Operating Cash Flow

-$876.71K

Capital Expenditure

$2.00

Free Cash Flow

-$876.71K

Cash & ST Invst.

$44.80K

Total Debt

$1.39M

Curative Biotechnology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$21.78K

+0.7%

Gross Margin

0.00%

N/A

Market Cap

$8.18M

N/A

Market Cap/Employee

$2.05M

N/A

Employees

N/A

Net Income

-$370.27K

+23.2%

EBITDA

-$272.10K

-4.7%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$44.80K

-79.5%

Total Debt

$1.39M

-55.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$1.39M

-55.4%

Return on Assets

-1.03%

N/A

Return on Invested Capital

24.26%

N/A

Free Cash Flow

-$193.12K

-4.2%

Operating Cash Flow

-$193.12K

-4.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

TXTMProText Mobility, Inc.

TXTMProText Mobility, Inc.$0.00+2.08%

CPMVMosaic ImmunoEngineering Inc.

CPMVMosaic ImmunoEngineering Inc.$0.67+0.00%

BVAXFBioVaxys Technology Corp.

BVAXFBioVaxys Technology Corp.$0.12-6.47%

THERTheralink Technologies, Inc.

THERTheralink Technologies, Inc.$0.00+0.00%

FAMDFFutura Medical plc

FAMDFFutura Medical plc$0.00-33.33%

NSHSFNanoSphere Health Sciences Inc.

NSHSFNanoSphere Health Sciences Inc.$0.01+0.00%

BETRFBetterLife Pharma Inc.

BETRFBetterLife Pharma Inc.$0.11+10.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$18.07+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.16+0.04%

PATHUiPath

PATHUiPath$10.87+0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.21-0.05%

RKTRocket Companies

RKTRocket Companies$15.75+0.02%

CMCSAComcast

CMCSAComcast$24.55+0.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$81.00+0.05%

Questions About CUBT

What is the current price of Curative Biotechnology?

Curative Biotechnology is trading at $0.90 per share.

What is the 52-week range for Curative Biotechnology?

Over the past 52 weeks, Curative Biotechnology has traded between $0.03 and $1.99.

How much debt does Curative Biotechnology have?

As of the most recent reporting period, Curative Biotechnology reported total debt of $1.39M.

How much cash does Curative Biotechnology have on hand?

Curative Biotechnology reported $44.80K in cash and cash equivalents in its most recent financial results.

What is Curative Biotechnology’s dividend yield?

Curative Biotechnology does not currently have a dividend yield.

Curative Biotechnology

Curative Biotechnology Financials at a Glance

CUBT News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Curative Biotechnology

CUBT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Curative Biotechnology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CUBT

What is the current price of Curative Biotechnology?

What is the 52-week range for Curative Biotechnology?

How much debt does Curative Biotechnology have?

How much cash does Curative Biotechnology have on hand?

What is Curative Biotechnology’s dividend yield?

Premium Investing Services